Log in

Relevant bibliographies by topics / Bone marrow / Journal articles

Journal articles on the topic 'Bone marrow'

To see the other types of publications on this topic, follow the link: Bone marrow.

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Bone marrow.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Varma, Amit, Ashok K. Rajoreya, Priyanka Kiyawat, Kamal Malukani, Shilpi Dosi, and Sudarshan Gupta. "Utility of Bone Marrow Aspiration and Bone Marrow Biopsy in Haematological Disorders." Indian Journal of Pathology: Research and Practice 7, no. 4 (2018): 517–23. http://dx.doi.org/10.21088/ijprp.2278.148x.7418.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kulandaivel, Anbu Lenin, and Kumudhini Priya Gunasekaran. "A A Correlative Study on Bone Marrow Angiogenesis with Bone Marrow Fibrosis and Splenomegaly." Annals of Pathology and Laboratory Medicine 5, no. 8 (August 19, 2018): A722–728. http://dx.doi.org/10.21276/apalm.2120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sengupta, Dr Moumita, Dr Kaushik Saha, and Dr chetna J. Mistry. "Bone Marrow Aspiration Study in Thrombocytopenia." International Journal of Scientific Research 1, no. 7 (June 1, 2012): 136–39. http://dx.doi.org/10.15373/22778179/dec2012/48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Khatik, Dr Daleep Kumar. "A Relevance Study of Bone Marrow Aspiration and Bone Marrow Biopsy in Haematological and Non Haematological Disorders." Journal of Medical Science And clinical Research 05, no. 04 (April 27, 2017): 20900–20908. http://dx.doi.org/10.18535/jmscr/v5i4.184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

NIKOLAEVA, L. P. "pH OF BONE MARROW." Periódico Tchê Química 16, no. 32 (August 20, 2019): 388–94. http://dx.doi.org/10.52571/ptq.v16.n32.2019.406_periodico32_pgs_388_394.pdf.

Full text

Abstract:

The bone marrow is a “niche” for stem cells; determining the bone marrow pH value is of great importance. It is very difficult, almost impossible, to carry out the intravital determination of pH. In surgical practice, there are situations when doctors have no way to save the patient's lower limb because of the threat to life. In such cases, it is possible to extract the bone marrow from the bone marrow cavity of the amputated femur and examine it. The purpose of this research was to study the acid-base balance peculiarities of the marrow of long bones and carry out a comparative analysis of the obtained data and the indicators of flat bones. The study included 40 test samples of bone marrow. Lower limb amputations were performed because of foot gangrene. Bone marrow was extracted from the femur. The marrow of flat bones was obtained by a sternal puncture. In the pH test of the sternal puncture, the data varied within the range of the blood pH, i.e., between 7.35-7.45 and 7.8. The pH and gas composition data of the sternal puncture were identical to the blood indicators. The data of bone marrow obtained from the long bone was completely different. The acid-base balance strictly ranged from 6.7 to 6.9.

APA, Harvard, Vancouver, ISO, and other styles

6

Harness, Mary, Charlotte Bloodworth, and Cath Lloyd. "Bone marrow." Cancer Nursing Practice 6, no. 6 (July 2007): 14–16. http://dx.doi.org/10.7748/cnp.6.6.14.s15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Libby, Peter. "Bone Marrow." Circulation 108, no. 4 (July 29, 2003): 378–79. http://dx.doi.org/10.1161/01.cir.0000084801.04026.7b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Unger, Evan C., and Thomas B. Summers. "Bone marrow." Topics in Magnetic Resonance Imaging 1, no. 4 (September 1989): 31???52. http://dx.doi.org/10.1097/00002142-198909000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Murphy, Darra T., Michael R. Moynagh, Stephen J. Eustace, and Eoin C. Kavanagh. "Bone Marrow." Magnetic Resonance Imaging Clinics of North America 18, no. 4 (November 2010): 727–35. http://dx.doi.org/10.1016/j.mric.2010.07.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gribben, J. G., and L. M. Nadler. "Bone Marrow Purging for Autologous Bone Marrow Transplantation." Leukemia & Lymphoma 11, sup2 (January 1993): 141–48. http://dx.doi.org/10.3109/10428199309064274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Lakhani, Dr Alpa, Dr Gayatri H. Bamaniya, Dr Krishna K. Lakhani, Dr Ajay M. Rathod, and Dr M. D. Gajjar Dr. M.D.Gajjar. "Bone Marrow Trephine Biopsy in Hematological Disorders." International Journal of Scientific Research 3, no. 6 (June 1, 2012): 265–67. http://dx.doi.org/10.15373/22778179/june2014/84.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Gerds, Aaron T., and Bart L. Scott. "Last Marrow Standing: Bone Marrow Transplantation for Acquired Bone Marrow Failure Conditions." Current Hematologic Malignancy Reports 7, no. 4 (October 14, 2012): 292–99. http://dx.doi.org/10.1007/s11899-012-0138-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mahabir, Vishwanath Kishan, Cathy Ross, Snezana Popovic, Jacqueline Bourgeois, Grace Wang, James N. George, Wendy Lim, John G. Kelton, and Donald M. Arnold. "The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia." Blood 116, no. 21 (November 19, 2010): 3691. http://dx.doi.org/10.1182/blood.v116.21.3691.3691.

Full text

Abstract:

Abstract Abstract 3691 Background: The utility of bone marrow examinations for the investigation of patients with immune thrombocytopenia (ITP) is a matter of debate. We designed an agreement study to evaluate the inter-rater reliability of bone marrow biopsies and aspirates for the diagnosis of ITP. Methods: Histological slides of bone marrow biopsies from patients with ITP and controls were prepared from stored tissue blocks and corresponding aspirate slides were retrieved for blinded, duplicate, independent pathological review. Patients had a diagnosis of primary ITP, were 18 years of age or older with a platelet count less than 100 ×109/L as measured within 4 weeks before the date of bone marrow biopsy procurement. Patients with splenomegaly, myelodysplastic syndrome, lymphoproliferative disease, HIV, hepatitis B or C, drug-induced thrombocytopenia or previous treatment with hematopoietic growth factors or thrombopoietin receptor agonists were excluded. Control bone marrow samples were selected from patients 18 years of age or older with stage I to III lymphoma or monoclonal gammopathy of undetermined significance who had a normal platelet count within 4 weeks before bone marrow biopsy procurement. Prior treatment with anti-neoplastic agents or hematopoietic growth factors were exclusions. Bone marrow slides from ITP patients and controls were coded and arranged in random order. A standardized pathological assessment form was used to capture bone marrow cellularity (in deciles), diagnosis [‘ITP’ or ‘within normal limits (wnl)’], megakaryocyte number (increased, decreased or wnl), morphology (abnormal or wnl), distribution (abnormal or wnl) and megakaryocyte assessment on aspirate (abnormal or wnl). The form was piloted by a third independent hematopathologist (n=10 bone marrow examinations) and revised prior to duplicate review. All reviewers were pathologists with at least 5 years experience reading bone marrows. Chance-corrected agreement between reviewers was calculated using kappa (k) and chance-independent agreement was calculated using phi (φ) with 95% confidence intervals (CI). Results: Bone marrow slides were prepared from 30 ITP patients and 53 controls. Agreement on marrow cellularity (to within 20%), which was used to ensure calibration of assessors, was good (k= 0.75, 95% CI. 0.65–0.85). Of 81 evaluable bone marrows, pathologists agreed on the diagnosis for 69 cases (85.2%); overall agreement was fair (φ = 0.52; 95% CI: 0.10–0.78). Of the 30 ITP bone marrows, pathologists correctly agreed on the diagnosis in 2 (6.7%) cases, incorrectly agreed on 20 (66.7%) and disagreed on 8 (26.7%). Of the 51 control bone marrows, pathologists correctly agreed on the diagnosis in 46 (90.2%) cases, incorrectly agreed on 1 (2.0%) and disagreed on 4 (7.8%). Agreement on megakaryocyte number, morphology and distribution was fair. Conclusions: Inter-rater reliability of bone marrow examinations for the diagnosis of ITP was fair. Pathologists often incorrectly agreed that ITP bone marrows were considered to be within normal limits. These data suggest that ITP bone marrows often do not exhibit any distinguishing features. Disclosures: No relevant conflicts of interest to declare.

APA, Harvard, Vancouver, ISO, and other styles

14

Van Deerlin, Vivianna M. D., and Debra G. B. Leonard. "Bone Marrow Engraftment Analysis After Allogeneic Bone Marrow Transplantation." Clinics in Laboratory Medicine 20, no. 1 (March 2000): 197–225. http://dx.doi.org/10.1016/s0272-2712(18)30083-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Mehta, Parinda, Franco Locatelli, Jan Stary, and Franklin O. Smith. "Bone Marrow Transplantation for Inherited Bone Marrow Failure Syndromes." Pediatric Clinics of North America 57, no. 1 (February 2010): 147–70. http://dx.doi.org/10.1016/j.pcl.2010.01.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

ROLAND, J., B. BRANS, A. VERVAET, C. GOORT, J. SERVAISI, P. DE MEYEREI, D. VAN DEN WIJNGAERT, J. VANDEVIVERE, and P. SCALLIET. "Bone marrow content measured in radioimmune bone marrow scintigraphy." Nuclear Medicine Communications 20, no. 5 (May 1999): 419–26. http://dx.doi.org/10.1097/00006231-199905000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Önal, İbrahi̇m Koral, Hale Sümer, Abdurrahman Tufan, and Ali Shorbagi. "Bone marrow embolism after bone marrow aspiration and biopsy." American Journal of Hematology 78, no. 2 (January 28, 2005): 158. http://dx.doi.org/10.1002/ajh.20061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

MA, Abdel-AAl. "Adjunctive bone grafting for symptomatic meniscal tearing with concomitant bone marrow edema." Orthopaedics and Surgical Sports Medicine 01, no. 02 (October 30, 2018): 01–02. http://dx.doi.org/10.31579/2641-0427/007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Conlan, M. G., M. Bast, J. O. Armitage, and D. D. Weisenburger. "Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group." Journal of Clinical Oncology 8, no. 7 (July 1990): 1163–72. http://dx.doi.org/10.1200/jco.1990.8.7.1163.

Full text

Abstract:

Bone marrow specimens from 317 patients with non-Hodgkin's lymphoma (NHL) obtained at initial staging were evaluated for the presence of lymphoma or benign lymphoid aggregates. Thirty-two percent (102 patients) had lymphoma in their bone marrow, and 9% had benign lymphoid aggregates. Bone marrow lymphoma was present in 39% of low-grade, 36% of intermediate-grade, and 18% of high-grade lymphomas. The bone marrow was involved in 25% of patients with diffuse large-cell or immunoblastic NHL (ie, diffuse histiocytic lymphoma of Rappaport). Bone marrow involvement did not affect survival of patients with low-grade NHL, but survival was significantly shorter (P = .03) for patients with intermediate- and high-grade NHL with bone marrow involvement. Bone marrow involvement was equally common in B-cell and T-cell NHL (31% v 32%). However, patients with T-cell NHL and bone marrow involvement had shorter survival than B-cell NHL with marrow involvement (P = .02) or T-cell NHL without marrow involvement (P = .05). A high incidence of morphologic discordance between lymph node and bone marrow was observed (ie, 40%), always with a more aggressive subtype in the lymph node than in the bone marrow. Presence of large-cell lymphoma in the bone marrow predicted for short survival. Survival for patients with small-cell lymphoma in their bone marrow did not differ significantly from patients with negative bone marrows. We conclude that bone marrow involvement in large-cell NHL, especially in those of T-cell origin, portends a poor prognosis. However, the subgroup of patients with an aggressive histologic subtype of NHL in a lymph node biopsy and small-cell NHL in the bone marrow do not have a poorer outlook than those without bone marrow involvement.

APA, Harvard, Vancouver, ISO, and other styles

20

Purita, Joseph, José Fábio Santos Duarte Lana, Morey Kolber, Bruno Lima Rodrigues, Tomas Mosaner, Gabriel Silva Santos, Carolina Caliari-Oliveira, and Stephany Cares Huber. "Bone marrow-derived products: A classification proposal – bone marrow aspirate, bone marrow aspirate concentrate or hybrid?" World Journal of Stem Cells 12, no. 4 (April 26, 2020): 241–50. http://dx.doi.org/10.4252/wjsc.v12.i4.241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

S Jaiswal K, Pendram. "Assessment of Diagnostic Values and Comparative Evaluation of Bone Marrow Aspiration and Bone Marrow Clot Section in Various Hematological Disorders." International Journal of Science and Research (IJSR) 12, no. 4 (April 5, 2023): 95–98. http://dx.doi.org/10.21275/sr23329010600.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Vincent, Paul. "Bone and bone‐marrow biopsy." Medical Journal of Australia 145, no. 11-12 (December 1986): 645. http://dx.doi.org/10.5694/j.1326-5377.1986.tb139525.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Lips, P., F. C. Van Ginkel, and J. C. Netelenbos. "Bone marrow and bone remodeling." Bone 6, no. 5 (1985): 343–44. http://dx.doi.org/10.1016/8756-3282(85)90327-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Anubrolu, Indira Priyadarshini, Rashmi K. Patil, and Shreekant K. Kittur. "Etio-Morphological Spectrum of Bone Marrow in Pancytopenia." Annals of Pathology and Laboratory Medicine 6, no. 1 (January 20, 2019): A24–31. http://dx.doi.org/10.21276/apalm.2208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kulkarni, Shruti V., Mahesh H. Karigoudar, Anita P. Javalgi, and Ambica Chalmeti. "Bone Marrow Iron Stores among Various Hematological Disorders." Indian Journal of Pathology: Research and Practice 6, no. 1 (2017): 83–87. http://dx.doi.org/10.21088/ijprp.2278.148x.6117.13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Smith, S. R., N. Roberts, and R. H. Edwards. "Marrow repopulation after bone marrow transplantation." Radiology 178, no. 2 (February 1991): 581. http://dx.doi.org/10.1148/radiology.178.2.1987631.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mansyrov, Asif Baglar ogly, Viktor Lytovchenko, Yevgeniy Garyachiy, and Andriy Lytovchenko. "BONE-CEREBRAL CHANNEL REAMING IN THE TREATMENT OF LIMBS BONE FRACTURES." ScienceRise, no. 6 (December 30, 2020): 40–50. http://dx.doi.org/10.21303/2313-8416.2020.001559.

Full text

Abstract:

The object of the study: clinical effect of intramedullary blocking osteosynthesis of fractures of the bones of the extremities without reaming of the bone marrow canal. The problem to be solved: determination of the influence of surgical technology of intramedullary blocking osteosynthesis of bone fractures without reaming of the bone marrow canal on the qualitative and anatomical and functional results of treatment. Main scientific results. The term of fusion of bone fragments in complete groups (including all localizations) in the group of patients who underwent surgery with reaming of the bone marrow canal was 4.21±0.46 months, while in the group without reaming of the canal it was much shorter – 3.47±0.51 months Faster functional recovery of the limbs was also observed in cases that precluded bone marrow reaming – 96 % of good and 4 % satisfactory scores were obtained (80 % good and 20 % satisfactory in bone marrow reaming). The technology of closed intramedullary blocking osteosynthesis without reaming of the bone marrow can optimize the time of fusion of bone fragments and get 91 % good and 9 % satisfactory results. Its effectiveness is to reduce the number of satisfactory treatment results by 19 %, the absence of unsatisfactory and increase the share of good results by 23 %. The area of practical use of research results: clinics of traumatological profile of different levels, in which surgical treatment of fractures of the bones of the extremities are done. An innovative technological product: technology of closed intramedullary blocking osteosynthesis without reaming of the bone marrow canal. The area of application of an innovative technological product: clinical practice of using the technology of closed intramedullary blocking osteosynthesis without reaming of the bone marrow canal.

APA, Harvard, Vancouver, ISO, and other styles

28

Al-Gwaiz, Layla A. "Bone Marrow Necrosis." Annals of Saudi Medicine 17, no. 3 (May 1997): 374–76. http://dx.doi.org/10.5144/0256-4947.1997.374.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Krishna, K. Ananda, and K. R. S. Sambasiva Rao. "Bone Marrow Transplantation." Open Biotechnology Journal 3, no. 1 (March 3, 2009): 24–30. http://dx.doi.org/10.2174/1874070700903010024.

Full text

Abstract:

Stem cells are the centre for regenerative medicine. Given a right signal these undifferentiated cells have a remarkable potential to develop into specialized cell types (blood cells, heart cells etc.) in the human body. Stem cells, therefore, can be used in cell-based therapies to replace/repair damaged tissues and/or organs. Ongoing research in the area of stem cells focuses on their potential application (both embryonic stem cells and adult stem cells) to create specialized cells and replace the damaged ones. Hence, this cutting-edge technology might lead to new ways of detecting and treating diseases. Stem cell transplantation can be considered as an option for the treatment of certain type of cancers. This medical procedure can also be used to treat neurological diseases, autoimmune diseases, heart diseases, liver diseases, metabolic disorders, spinal cord injury etc. The present review, therefore, focuses on the growing use of stem cell transplantation in regenerative medicine to treat a variety of diseases. This review also provides the current status of the field with a particular emphasis on bone marrow transplantation.

APA, Harvard, Vancouver, ISO, and other styles

30

Babyn, Paul S., Marilyn Ranson, and Mary Elizabeth McCarville. "Normal Bone Marrow." Magnetic Resonance Imaging Clinics of North America 6, no. 3 (August 1998): 473–95. http://dx.doi.org/10.1016/s1064-9689(21)00233-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Williss, Janet. "Bone marrow transplantation." Paediatric Nursing 5, no. 7 (September 1993): 28–33. http://dx.doi.org/10.7748/paed.5.7.28.s17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Melkova, K. N., Zh V. Sharoyan, and G. P. Frolov. "BONE MARROW TRANSPLANTATION." Clinical oncohematology 13, no. 3 (2020): 273–79. http://dx.doi.org/10.21320/2500-2139-2020-13-3-273-279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Thomas, E. D. "Bone Marrow Transplantation." CA: A Cancer Journal for Clinicians 37, no. 5 (September 1, 1987): 291–301. http://dx.doi.org/10.3322/canjclin.37.5.291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Ford, Rosemary, and Seth Eisenberg. "Bone Marrow Transplant." Nursing Clinics of North America 25, no. 2 (June 1990): 405–22. http://dx.doi.org/10.1016/s0029-6465(22)02934-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Buchsel, Patricia Corcoran, and Joleen Kelleher. "Bone Marrow Transplantation." Nursing Clinics of North America 24, no. 4 (December 1989): 907–38. http://dx.doi.org/10.1016/s0029-6465(22)01552-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Szer, Jeffrey. "Bone marrow transplant." Medical Journal of Australia 170, no. 6 (March 1999): 258. http://dx.doi.org/10.5694/j.1326-5377.1999.tb127745.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

FURMAN, LYDIA. "Bone Marrow Transplants." Pediatrics 85, no. 2 (February 1, 1990): 237. http://dx.doi.org/10.1542/peds.85.2.237.

Full text

Abstract:

In Reply.— The first issue is whether or not bone marrow transplantation is, indeed, the most effective therapy available for children with leukemia. Drs Ogden and Steuber refer to "more than a decade of literature in which good responses after bone marrow transplantation have been reported." Likewise, Drs Weinblatt et al state that "the majority of patients currently receiving transplantation therapy for. . .leukemia in first remission are cured. . . ." However, Pinkel (Leukemia. 1989;3:242-244), in a recent editorial, carefully and succinctly reviewed the relevant data and concluded the exact opposite.

APA, Harvard, Vancouver, ISO, and other styles

38

OGDEN, ANGELA KENT, and C. PHILIP STEUBER. "Bone Marrow Transplants." Pediatrics 85, no. 2 (February 1, 1990): 235–36. http://dx.doi.org/10.1542/peds.85.2.235.

Full text

Abstract:

To the Editor.— Bone marrow transplantation has been increasingly undertaken and found effective for a variety of otherwise incurable diseases. As with all new therapies, the economic and ethical impact of the procedure requires continuing reevaluation. Durbin1 clearly stated the dilemmas faced by transplantation centers, insurance carriers, government agencies, and the public in general. Furman2 offered a limited view of transplantation and stated that bone marrow transplantation "may be neither ethical nor imperative as a therapy for dying children."

APA, Harvard, Vancouver, ISO, and other styles

39

Tarantino, Umberto, Chiara Greggi, Ida Cariati, Patrizio Caldora, Rodolfo Capanna, Antonio Capone, Roberto Civinini, et al. "Bone Marrow Edema." Journal of Bone and Joint Surgery 104, no. 2 (November 15, 2021): 189–200. http://dx.doi.org/10.2106/jbjs.21.00300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Svedentsov, E. P. "Bone marrow transplantation." Kazan medical journal 68, no. 5 (October 15, 1987): 378–81. http://dx.doi.org/10.17816/kazmj96535.

Full text

Abstract:

Bone marrow transplantation is an effective method of treatment of deep depressions of hematopoiesis of different origin. In this connection, the new method of treatment of the above pathology attracts the attention of specialists of different profiles.

APA, Harvard, Vancouver, ISO, and other styles

41

Santos, George W. "Bone marrow transplantation." Current Opinion in Oncology 2, no. 2 (April 1990): 249. http://dx.doi.org/10.1097/00001622-199004000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Santos, George W. "Bone marrow transplantation." Current Opinion in Oncology 3, no. 2 (April 1991): 233. http://dx.doi.org/10.1097/00001622-199104000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Bone marrow transplantation." Current Opinion in Oncology 3, no. 2 (April 1991): 385–419. http://dx.doi.org/10.1097/00001622-199104000-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Santos, George W. "Bone marrow transplantation." Current Opinion in ONCOLOGY 7, no. 2 (March 1995): 101. http://dx.doi.org/10.1097/00001622-199503000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Weisdorf, Daniel J. "Bone marrow transplantation." Postgraduate Medicine 87, no. 1 (January 1990): 91–101. http://dx.doi.org/10.1080/00325481.1990.11704524.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ekert, Henry. "Bone marrow transplantation." Medical Journal of Australia 153, no. 10 (November 1990): 573–74. http://dx.doi.org/10.5694/j.1326-5377.1990.tb126261.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Yasmeen, BH Nazma. "Bone marrow transplantation." Northern International Medical College Journal 5, no. 2 (April 29, 2015): 323–24. http://dx.doi.org/10.3329/nimcj.v5i2.23125.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

McWhinney, Paul H. M., and H. Grant Prentice. "Bone marrow transplantation." Current Opinion in Infectious Diseases 5, no. 3 (June 1992): 422–26. http://dx.doi.org/10.1097/00001432-199206000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Winfield, D. "Bone Marrow Pathology." Journal of Clinical Pathology 46, no. 6 (June 1, 1993): 584. http://dx.doi.org/10.1136/jcp.46.6.584-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Dilly, S. "Bone Marrow Pathology." Journal of Clinical Pathology 50, no. 7 (July 1, 1997): 622. http://dx.doi.org/10.1136/jcp.50.7.622-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!